Skip to content
WeighLab
Menu
Ranked #305 · Grade C

Alinwell review

Alinwell markets compounded GLP-1s to women from $149 a month, but that figure is a first-month discount: the standing rates are $249 for semaglutide and $299 for tirzepatide, and neither appears until checkout.

Visit Alinwell Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$249/mo month-to-month (charged every 30 days; the advertised $149 is the first month only)
Tirzepatide
$299/mo month-to-month (charged every 30 days; the advertised $199 is the first month only)
Coverage
All 50 states
Brand-name
Compounded only

Semaglutide · modeled / year

$2,988

Tirzepatide · modeled / year

$3,588

Pricing verified September 2026

The Index scorecard

Alinwell scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month46/100
Price Transparency30/100
Nationwide Access86/100
Formulation Options77/100
Clinical Oversight65/100
Contract Flexibility49/100

Where the value is

  • Links a certificate of analysis for each GLP-1 from the treatment page itself, naming the compounding pharmacy, the strength and the testing laboratory
  • The monthly figure includes physician review, care coaching, a dietitian visit and expedited shipping, with no separate consultation or dose-change fee
  • Three- and six-month rates are shown side by side at checkout rather than being quoted only on request
  • A low-dose GLP-1 program and a daily oral GLP-1 are sold alongside the standard injections

The tradeoffs

  • Every advertised price is an introductory one: "from $149/mo" and "from $199/mo" are labeled "$100 off first month" at checkout, with $249 and $299 struck through beside them
  • The three-month plan costs more per month than the advertised monthly figure ($219 against $149), because the advertised figure was never a rate
  • No clinician, medical group or prescriber is named anywhere on the site, and the About page contains no people
  • The four pharmacies are named only inside linked certificate PDFs; the site's own copy says nothing more specific than "partner compounding pharmacies", and 503A and 503B appear nowhere
  • Three incompatible cancellation rules are published at once: 48 hours' notice in the terms, 30 days' notice in the treatment-page FAQ, and "cancel anytime" at checkout
  • The terms and privacy policy print a template mailing address — "123 Example Street, Suite 100, Your City, WI, 92308" — while the contact page gives a real Texas one
  • Neither the low-dose program nor the oral program names its molecule on any page
  • The checkout runs a countdown reading "Approval expires in 14:56" and shows "You're Approved" before any clinician has seen the file

The bottom line

Best for: Readers who want to see the compounding certificates before they buy, and who will look past the advertised figure to the price that renews. Alinwell markets compounded GLP-1s to women from $149 a month, but that figure is a first-month discount: the standing rates are $249 for semaglutide and $299 for tirzepatide, and neither appears until checkout.

Ranked #305 of 529 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 528 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Alinwell.

The 24 programs nearest this one

Pricing, states and verification reflect Alinwell's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Alinwell's site. Not medical advice; see our disclosure.

← Back to the value leaderboard